Nasolacrimal Sac Biopsy in Endoscopic Dacryocystorhinostomy
NCT ID: NCT04793230
Last Updated: 2021-03-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2019-01-01
2021-03-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Color Doppler Ultrasound in Lacrimal Sac Space-occupying Lesions
NCT05500950
Endobronchial Mucosal Biopsy in Patients With Suspected Pulmonary Sarcoidosis
NCT04904939
Eosinophilic Cystitis Mimicking Urothelial Neoplasia
NCT04914442
Role of Cryobiopsy in Diagnosis of Pleural Effusion
NCT03828903
Forceps Biopsy Versus Cryo-biopsy in the Diagnosis of Lung Cancer
NCT05151419
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study included 50 patients with chronic unilateral epiphora. All patients underwent endoscopic dacryocystorhinostomy with nasolacrimal duct biopsy. Histopathologic analysis was performed for each specimen to assess the nature of the pathology.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
biopsying
The procedure was carried out under general or local anesthesia. An otolaryngologist conducts the endoscopic intranasal operation, while an eye surgeon removes tissue from the sac and lacrimal tubes using lacrimal probes passed through the canaliculi.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients asked for histopathology in private laboratories
20 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Al-Azhar University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Abdulkarim Hasan
pathology laboratory coordinator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ibrahim El-dsoky, MD
Role: PRINCIPAL_INVESTIGATOR
Al-Azhar University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Azhar faculty of medicine
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
19-11-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.